StockClub

CBIA

CBIACanopus Biopharma, Inc.$ --
Canopus Biopharma, Inc.

Canopus Biopharma, Inc.

CBIA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 05/31/2023FY2023 Q2
Revenue
0M USD
YoY -
Operating Income
-0M USD
YoY -5132.4%
Net Income
-0M USD
YoY -5499.9%
EPS
-0$
YoY -4311.8%

Revenue

$0
FY2021 Q3$0
$0
Q3
FY2021 Q4$0
$0
Q4
FY2022 Q1$0
$0
Q1
FY2022 Q2$0
$0
Q2
FY2022 Q3$0
$0
Q3
FY2022 Q4$0
$0
Q4
FY2023 Q1$0
$0
Q1
FY2023 Q2$0
$0
Q2
Actual
$0 (-)

Net Income

$-986,621
FY2021 Q3$-1,755
$-1,755
Q3
FY2021 Q4$-3,510
$-3,510
Q4
FY2022 Q1$-6,997
$-6,997
Q1
FY2022 Q2$-10,639
$-10,639
Q2
FY2022 Q3$-435,865
$-435,865
Q3
FY2022 Q4$-439,583
$-439,583
Q4
FY2023 Q1$-782,674
$-782,674
Q1
FY2023 Q2$-986,621
$-986,621
Q2
Actual
$-975,982 (-9173.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2012
Actual:$0
FY2012
$0
FY2013
Actual:$0
FY2013
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0

Analyst Estimates

No forecast data